RxDoctor Payments Data

Amy Gallagher

Nurse Practitioner · Spring Hill, FLNPI 1134674690

Payments from drug & device makers

$3,787in general payments, 2019–2025

Across 184 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$459
  • Incyte Corporation$338
  • Novartis$305
  • Bristol Myers Squibb$262
  • AstraZeneca$239
  • Eisai Inc.$225
  • plus $2K from 39 others

What the payments were for

  • Food & beverage$3,21485%
  • Education$57315%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,787 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$19,163
Duloxetine Hcl22$1,700
Midodrine Hcl18$1,151
Ondansetron OdtOndansetron35$1,129
Anastrozole41$834
Dexamethasone15$506
Acyclovir19$442
Gabapentin32$430
Omeprazole23$334
Prednisone37$311
Levothyroxine Sodium30$291
Hydroxyurea14$276
Albuterol Sulfate HfaAlbuterol Sulfate22$269
Methylprednisolone31$238
Doxycycline Hyclate15$215

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$40$19,16327 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Spring Hill

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →